INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 282 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,476 | -18.6% | 200 | 0.0% | 0.00% | – |
| Q1 2024 | $5,502 | -13.4% | 200 | 0.0% | 0.00% | – |
| Q4 2023 | $6,354 | +0.5% | 200 | 0.0% | 0.00% | – |
| Q3 2023 | $6,324 | -22.5% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $8,156 | +9.4% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $7,454 | +6.8% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $6,978 | -37.7% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $11,192 | +8.1% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $10,352 | -28.8% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $14,534 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |